Home » Topics » Inflammatory, BioWorld Science

Inflammatory, BioWorld Science
RSS

Vasopressin inhibition decreases mortality in jet-lagged mice

July 24, 2018

Fixing nuclear transport helps cells cope with premature, normal aging

July 11, 2018

Celtaxsys divulges new LTA-4 hydrolase inhibitors

July 5, 2018

Thinning out fat cells

July 2, 2018

Brain sleepiness signature, links to memory identified

June 19, 2018

Roche patents anti-pY796-DDR1 antibodies

June 8, 2018

Secarna Pharmaceuticals patents novel anti-CD39 immunosuppression-reverting oligonucleotides

May 8, 2018

Bristol-Myers Squibb presents new TYK2 inhibitors

April 25, 2018

Afecta Pharmaceuticals patents novel hgh mobility group protein B1 inhibitors

April 25, 2018

Novel calpain inhibitors identified at Blade Therapeutics

April 23, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...